MF

Mohammed Fazle Ekramul Hoque

Active Director Designated Partner DIN 10019553
DIN 10019553 First appointment Sep 2022 Primary industry Home Appliances
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammed Fazle Ekramul Hoque

Data last updated:

Mohammed Fazle Ekramul Hoque is a Designated Partner at Orikem Pharma Remedies Llp (since 2022). The company operates in Home Appliances.

DIN 10019553
Primary Designation Designated Partner
Industry Home Appliances
First Appointment 13 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Sep 20222022Active

Board colleagues of Mohammed Fazle Ekramul Hoque

NameDINCompanyDesignation
Maharunnesa Khatun10019554Orikem Pharma Remedies LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Orikem Pharma Remedies Llp
Premium access

Shareholding and investment profile for Mohammed Fazle Ekramul Hoque

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Fazle Ekramul Hoque

Mohammed Fazle Ekramul Hoque currently holds 1 directorship: Orikem Pharma Remedies Llp (Designated Partner, since 13 Sep 2022).

Mohammed Fazle Ekramul Hoque was first appointed on 13 Sep 2022 as Designated Partner at Orikem Pharma Remedies Llp.

The current boards of Mohammed Fazle Ekramul Hoque's companies include Maharunnesa Khatun (Orikem Pharma Remedies Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available